Germline BRCA2 Mutation is not Associated with Increased Tumor-Infiltrating Lymphocytes in Primary Prostate Cancer

被引：0
|
作者：
Kaur, Harsimar [1 ]
Isaacs, William [2 ]
Hicks, Jessica [2 ]
De Marzo, Angelo [1 ]
Antonarakis, Emmanuel [2 ]
Lotan, Tamara [3 ]
机构：
[1] Johns Hopkins Univ, Baltimore, MD USA
[2] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
[3] Johns Hopkins Sch Med, Baltimore, MD USA
来源：
MODERN PATHOLOGY | 2019年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
878
引用
下载
收藏
页数：1
相关论文
共 50 条
  • [1] Germline BRCA2 Mutation is not Associated with Increased Tumor-Infiltrating Lymphocytes in Primary Prostate Cancer
    Kaur, Harsimar
    Isaacs, William
    Hicks, Jessica
    De Marzo, Angelo
    Antonarakis, Emmanuel
    Lotan, Tamara
    LABORATORY INVESTIGATION, 2019, 99
  • [2] Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer
    Harsimar B. Kaur
    Thiago Vidotto
    Adrianna A. Mendes
    Daniela C. Salles
    William B. Isaacs
    Emmanuel S. Antonarakis
    Tamara L. Lotan
    Cancer Immunology, Immunotherapy, 2022, 71 : 943 - 951
  • [3] Association between pathogenic germline mutations in BRCA2 and ATM and tumor-infiltrating lymphocytes in primary prostate cancer
    Kaur, Harsimar B.
    Vidotto, Thiago
    Mendes, Adrianna A.
    Salles, Daniela C.
    Isaacs, William B.
    Antonarakis, Emmanuel S.
    Lotan, Tamara L.
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2022, 71 (04) : 943 - 951
  • [4] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
    S M Edwards
    D G R Evans
    Q Hope
    A R Norman
    Y Barbachano
    S Bullock
    Z Kote-Jarai
    J Meitz
    A Falconer
    P Osin
    C Fisher
    M Guy
    S G Jhavar
    A L Hall
    L T O'Brien
    B N Gehr-Swain
    R A Wilkinson
    M S Forrest
    D P Dearnaley
    A T Ardern-Jones
    E C Page
    D F Easton
    R A Eeles
    British Journal of Cancer, 2010, 103 : 918 - 924
  • [5] Prostate cancer in BRCA2 germline mutation carriers is associated with poorer prognosis
    Edwards, S. M.
    Evans, D. G. R.
    Hope, Q.
    Norman, A. R.
    Barbachano, Y.
    Bullock, S.
    Kote-Jarai, Z.
    Meitz, J.
    Falconer, A.
    Osin, P.
    Fisher, C.
    Guy, M.
    Jhavar, S. G.
    Hall, A. L.
    O'Brien, L. T.
    Gehr-Swain, B. N.
    Wilkinson, R. A.
    Forrest, M. S.
    Dearnaley, D. P.
    Ardern-Jones, A. T.
    Page, E. C.
    Easton, D. F.
    Eeles, R. A.
    BRITISH JOURNAL OF CANCER, 2010, 103 (06) : 918 - 924
  • [6] TP53 missense mutation is associated with increased tumor-infiltrating T cells in primary prostate cancer
    Kaur, Harsimar B.
    Lu, Jiayun
    Guedes, Liana B.
    Maldonado, Laneisha
    Reitz, Logan
    Barber, John R.
    De Marzo, Angelo M.
    Tomlins, Scott A.
    Sfanos, Karen S.
    Eisenberger, Mario
    Schaeffer, Edward M.
    Joshu, Corinne E.
    Lotan, Tamara L.
    HUMAN PATHOLOGY, 2019, 87 : 95 - 102
  • [7] Loss of heterozygosity at the BRCA2 locus is a common finding in prostate cancer in men with a germline BRCA2 mutation
    Dawson, S.
    Willems, A.
    Thorne, H.
    Samaratunga, H.
    Antill, Y. C.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [8] BRAF inhibition is associated with increased clonality in tumor-infiltrating lymphocytes
    Cooper, Zachary A.
    Frederick, Dennie T.
    Juneja, Vikram R.
    Sullivan, Ryan J.
    Lawrence, Donald P.
    Piris, Adriano
    Sharpe, Arlene H.
    Fisher, David E.
    Flaherty, Keith T.
    Wargo, Jennifer A.
    ONCOIMMUNOLOGY, 2013, 2 (10):
  • [9] Tumor-infiltrating lymphocytes in primary tumors of colorectal cancer and their metastases
    Jakubowska, Katarzyna
    Koda, Mariusz
    Kisielewski, Wojciech
    Kanczuga-Koda, Luiza
    Famulski, Waldemar
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2019, 18 (06) : 4904 - 4912
  • [10] Pregnancy-associated breast cancer in BRCA1 and BRCA2 germline mutation carriers
    Johannsson, O
    Loman, N
    Borg, Å
    Olsson, H
    LANCET, 1998, 352 (9137): : 1359 - 1360
12345